Join leading experts for a focused discussion on how New Approach Methodologies (NAMs), including organoids, micro‑physiological systems, organs‑on‑a‑chip, and advanced AI‑driven models are transforming precision medicine. With nearly 90% of drugs that succeed in animal models failing in human trials, NAMs offer a more accurate path to predicting treatment response, improving outcomes, and lowering overall health care costs.

How NAMs improve the predictive power of preclinical models.

Why patient‑specific data and diverse representation matter.

Opportunities and challenges in bringing NAMs into clinical practice.

Kambez Benam, D.Phil. (Oxon), ATSF – University of Pittsburgh (Moderator)

Christine Happel, PhD – National Institutes of Health

Joseph Wu, MD, PhD – Stanford University School of Medicine

Researchers, clinicians, biotech, pharma, health care innovators, and anyone interested in the future of precision medicine and human‑based models.

Enhancing Predictive Outcomes: New Approach Methodologies (NAMs) at the Frontline of Precision Medicine